Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends.

Autor: Mengdi Cao¹, Changfa Xia¹, Maomao Cao¹, Fan Yang¹, Xinxin Yan¹, Siyi He¹, Shaoli Zhang¹, Yi Teng¹, Qianru Li¹, Nuopei Tan¹, Jiachen Wang¹, Wanqing Chen¹ chenwq@cicams.ac.cn

Publikováno v: Cancer Biology & Medicine. Aug2024, Vol. 21 Issue 8, p679-691. 13p.

Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.

Autor: Natarajan Y; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA. Yamini.Natarajan@va.gov., White DL; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Texas Medical Center Digestive Disease Center, Houston, TX, USA.; Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, TX, USA.; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA., El-Serag HB; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Texas Medical Center Digestive Disease Center, Houston, TX, USA.; Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, TX, USA., Ramsey D; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA., Richardson P; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA., Kuzniarek J; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA., Shukla R; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA., Tansel A; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA., Kanwal F; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, TX, USA.; Texas Medical Center Digestive Disease Center, Houston, TX, USA.; Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, TX, USA.

Publikováno v: Digestive diseases and sciences [Dig Dis Sci] 2017 Jan; Vol. 62 (1), pp. 76-83. Date of Electronic Publication: 2016 Sep 21.

Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.

Autor: Khalaf N; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., White D; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., Kanwal F; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., Ramsey D; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., Mittal S; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., Tavakoli-Tabasi S; Section of Infectious Diseases, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., Kuzniarek J; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas., El-Serag HB; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas; Section of Health Services Research, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas. Electronic address: hasheme@bcm.edu.

Publikováno v: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2015 Aug; Vol. 13 (8), pp. 1521-31.e3. Date of Electronic Publication: 2015 Mar 14.

Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males.

Autor: White DL; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Texas Medical Center Digestive Disease Center Houston, TX, USA ; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA ; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center Houston, TX, USA., Liu Y; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA ; Department of Pediatrics, Baylor College of Medicine Houston, TX, USA., Garcia J; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA ; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center Houston, TX, USA ; Section of Endocrinology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA., El-Serag HB; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Texas Medical Center Digestive Disease Center Houston, TX, USA ; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA., Jiao L; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Texas Medical Center Digestive Disease Center Houston, TX, USA ; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA ; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center Houston, TX, USA., Tsavachidis S; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA ; Department of Pediatrics, Baylor College of Medicine Houston, TX, USA., Franco LM; Department of Molecular and Human Genetics, Baylor College of Medicine Houston, TX, USA., Lee JS; Department of Systems Biology, MD Anderson Cancer Center Houston, TX, USA., Tavakoli-Tabasi S; Section of Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine Houston, TX, USA., Moore D; Department Molecular and Cell Biology and Department of Medicine, Baylor College of Medicine Houston, TX, USA., Goldman R; Department of Oncology, Georgetown University Medical Center Washington, DC, USA., Kuzniarek J; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA., Ramsey DJ; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA., Kanwal F; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuESt), Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA ; Texas Medical Center Digestive Disease Center Houston, TX, USA ; Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, TX, USA., Marcelli M; Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center Houston, TX, USA ; Section of Endocrinology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine Houston, TX, USA.

Publikováno v: International journal of molecular epidemiology and genetics [Int J Mol Epidemiol Genet] 2014 Oct 22; Vol. 5 (3), pp. 164-76. Date of Electronic Publication: 2014 Oct 22 (Print Publication: 2014).

Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.

Autor: Wan Y; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China., Jiang H; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China., Liu Z; Department of VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China., Bai C; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China., Lian Y; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China., Zhang C; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China., Zhang Q; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China., Huang J; Department of Acupuncture and Mini-invasive Oncology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, 100029, China.

Publikováno v: Current pharmaceutical design [Curr Pharm Des] 2024; Vol. 30 (24), pp. 1894-1911.